Bonegraft continues its R&D studies on synthetic bone tissue and cartilage tissue scaffolds in the biomedical sector as of 2015. In January 2017, the Bonegraft R&D laboratory was established at the Ege University Technology Development Center under ISO-7 (Class 10000) clean room conditions. Bonegraft is a biotechnology-based company focused on the design, development, manufacture and marketing of innovative synthetic bone graft products. In addition to its high-tech production and quality control devices, it continues its R&D investments with its expert employees and strong capital structure.

It provides all national and international quality, management and product documents to its customers in line with the requirements of the industry, which makes the mass production stages in-house and sterilizes the end-user product. They continue to work with sure and determined steps to become a globally respected and sought-after company in the health sector.All stages of design, production and product are under constant supervision by certification bodies, the Ministry of Health and our customers. Bonegraft has adopted the principle of working with the discipline given by these controls. https://bonegraft.com.tr